These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20816389)

  • 1. [Cardiovascular morbidity and mortality and electrocardiographic criteria of left ventricular hypertrophy in hypertensive patients treated in primary care].
    Tovillas-Morán FJ; Vilaplana-Cosculluela M; Zabaleta-del-Olmo E; Dalfó-Baqué A; Galcerán JM; Coca A
    Med Clin (Barc); 2010 Sep; 135(9):397-401. PubMed ID: 20816389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of electrocardiographic criteria for left ventricular hypertrophy in hypertensive patients in general practice.
    Van Den Hoogen JP; Mol WH; Kowsoleea A; Van Ree JW; Thien T; Van Weel C
    Eur Heart J; 1992 Dec; 13(12):1606-10. PubMed ID: 1289088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta-analysis of electrocardiographic studies.
    Zhang H; Hu L; Wei X
    J Clin Hypertens (Greenwich); 2020 Feb; 22(2):254-260. PubMed ID: 31955500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: A meta-analysis.
    Yi S; Wang F; Wan M; Yi X; Zhang Y; Sun S
    J Electrocardiol; 2020; 61():27-31. PubMed ID: 32504899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study.
    Verdecchia P; Dovellini EV; Gorini M; Gozzelino G; Lucci D; Milletich A; Maggioni AP
    Ital Heart J; 2000 Mar; 1(3):207-15. PubMed ID: 10806988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects.
    Antikainen RL; Grodzicki T; Beevers DG; Webster J; Jokelainen JJ; Bulpitt CJ
    J Hum Hypertens; 2009 Jan; 23(1):20-6. PubMed ID: 18754020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular morbidity and mortality and left ventricular geometric patterns in hypertensive patients treated in primary care.
    Tovillas-Morán FJ; Zabaleta-del-Olmo E; Dalfó-Baqué A; Vilaplana-Cosculluela M; Galcerán JM; Coca A
    Rev Esp Cardiol; 2009 Mar; 62(3):246-54. PubMed ID: 19268068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of non-specific ST-T changes and left ventricular hypertrophy electrocardiographic criteria in hypertensive patients: 16-year follow-up results from the MINACOR cohort.
    Vinyoles E; Soldevila N; Torras J; Olona N; de la Figuera M
    BMC Cardiovasc Disord; 2015 Mar; 15():24. PubMed ID: 25887937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability and concordance of Cornell and Sokolow-Lyon electrocardiographic criteria in hypertensive patients.
    Vinyoles E; Rodriguez-Blanco T; de la Figuera M; Colomé JM; Tafalla M; Calbet N; Fernández-San Martin MI; García-Alonso J; Murillo C; Agudo J
    Blood Press; 2012 Dec; 21(6):352-9. PubMed ID: 22587668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular prognosis in patients with type 2 diabetes: contribution of heart and kidney subclinical damage.
    Sosner P; Hulin-Delmotte C; Saulnier PJ; Cabasson S; Gand E; Torremocha F; Piguel X; Miot A; Maréchaud R; Herpin D; Ragot S; Hadjadj S;
    Am Heart J; 2015 Jan; 169(1):108-14.e7. PubMed ID: 25497255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data).
    Greve AM; Gerdts E; Boman K; Gohlke-Baerwolf C; Rossebø AB; Hammer-Hansen S; Køber L; Willenheimer R; Wachtell K
    Am J Cardiol; 2011 Aug; 108(4):541-7. PubMed ID: 21624542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.